| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1107916789 |
| P356 | DOI | 10.1186/S40560-018-0342-4 |
| P932 | PMC publication ID | 6206635 |
| P698 | PubMed publication ID | 30397481 |
| P50 | author | Andrea Cortegiani | Q38545310 |
| Anuradha Chowdhary | Q42337778 | ||
| P2093 | author name string | Anna Giammanco | |
| Teresa Fasciana | |||
| Antonino Giarratano | |||
| Giovanni Misseri | |||
| P2860 | cites work | Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients | Q24186457 |
| Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy | Q26745677 | ||
| Invasive Infections with Multidrug-Resistant Yeast Candida auris, Colombia | Q28818814 | ||
| Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species | Q28829671 | ||
| Multidrug-resistant Candida auris: 'new kid on the block' in hospital-associated infections? | Q30245326 | ||
| Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital | Q33401940 | ||
| Biofilm formation and genotyping of Candida haemulonii, Candida pseudohaemulonii, and a proposed new species (Candida auris) isolates from Korea. | Q33609053 | ||
| Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally | Q33704302 | ||
| Current perspective on emergence, diagnosis and drug resistance in Candida auris | Q33812143 | ||
| First three reported cases of nosocomial fungemia caused by Candida auris | Q34196357 | ||
| New clonal strain of Candida auris, Delhi, India | Q34372060 | ||
| Draft genome of a commonly misdiagnosed multidrug resistant pathogen Candida auris | Q34492906 | ||
| Invasive Candidiasis | Q34497221 | ||
| Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America | Q34505582 | ||
| First hospital outbreak of the globally emerging Candida auris in a European hospital | Q34543358 | ||
| Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses | Q34547546 | ||
| Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek | Q35586995 | ||
| Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism. | Q35835357 | ||
| Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry | Q36049838 | ||
| Identification of Uncommon Candida Species Using Commercial Identification Systems | Q36155872 | ||
| Matrix-assisted laser desorption ionization time of flight mass spectrometry (MALDI-TOF MS) for rapid identification of micro-organisms in the routine clinical microbiology laboratory | Q36227115 | ||
| Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations | Q36856930 | ||
| Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel | Q37664411 | ||
| Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature. | Q37708398 | ||
| Mechanisms of Antifungal Drug Resistance | Q38266675 | ||
| Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface | Q38659451 | ||
| Candida auris candidaemia in Indian ICUs: analysis of risk factors | Q38883902 | ||
| The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. | Q38949297 | ||
| Donor-derived transmission of Candida auris during lung transplantation | Q39092106 | ||
| Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins. | Q39092125 | ||
| Effectiveness of Disinfectants Against Candida auris and Other Candida Species | Q39092133 | ||
| First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia | Q39092138 | ||
| Incidence, characteristics and outcome of ICU-acquired candidemia in India | Q39092143 | ||
| Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016. | Q50985111 | ||
| Candida auris, what do paediatricians need to know? | Q51149128 | ||
| Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention. | Q51782681 | ||
| Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. | Q51782762 | ||
| Candida auris Infection Leading to Nosocomial Transmission, Israel, 2017. | Q51783505 | ||
| First case of Candida auris in Switzerland: discussion about preventive strategies. | Q52561182 | ||
| Understanding echinocandin resistance in the emerging pathogen Candida auris. | Q52597955 | ||
| Fungicidal potency and mechanisms of θ-defensins against multi-drug resistant Candida species. | Q52611998 | ||
| Candida auris: Disinfectants and Implications for Infection Control. | Q53690366 | ||
| An outbreak due to Candida auris with prolonged colonization and candidemia in a tertiary care European hospital. | Q53695503 | ||
| Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida species. | Q53704744 | ||
| Hospital transmitted Candida auris infections confirmed in the US. | Q53762019 | ||
| In Vitro Activity of a Novel Glucan Synthase Inhibitor, SCY-078, against Clinical Isolates of Candida auris. | Q53789385 | ||
| Five-year profile of candidemia at an Indian Trauma Center: high rates of Candida auris blood stream infections. | Q54218129 | ||
| Candida auris: epidemiological situation, laboratory capacity and preparedness in European Union and European Economic Area countries, 2013 to 2017. | Q54242269 | ||
| First reported case of multidrug-resistant Candida auris in Canada. | Q55017741 | ||
| The first isolate of Candida auris in China: clinical and biological aspects. | Q55312173 | ||
| Molecular Epidemiology of Candida auris in Colombia Reveals a Highly Related, Countrywide Colonization With Regional Patterns in Amphotericin B Resistance | Q64137661 | ||
| Emerging Multidrug-Resistant Candida duobushaemulonii Infections in Panama Hospitals: Importance of Laboratory Surveillance and Accurate Identification | Q64137940 | ||
| Notes from the Field: Surveillance for Candida auris - Colombia, September 2016-May 2017. | Q64991277 | ||
| First report of Candida auris in Oman: Clinical and microbiological description of five candidemia cases | Q88232114 | ||
| The comparative efficacy of antiseptics against Candida auris biofilms | Q88727573 | ||
| First report of Candida auris infections from Saudi Arabia | Q89080493 | ||
| What's new on emerging resistant Candida species | Q91324609 | ||
| Multidrug-resistant endemic clonal strain of Candida auris in India. | Q39092162 | ||
| Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris | Q39092215 | ||
| Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis | Q39092224 | ||
| Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection | Q39092240 | ||
| The first cases of Candida auris candidaemia in Oman | Q39092264 | ||
| Candida auris: a worrisome, globally emerging pathogen | Q39092282 | ||
| Nosocomial fungemia by Candida auris: First four reported cases in continental Europe. | Q39092317 | ||
| Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variation | Q39092330 | ||
| Biofilm-Forming Capability of Highly Virulent, Multidrug-Resistant Candida auris. | Q39092336 | ||
| Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities - United States, June 2016-May 2017. | Q39092357 | ||
| Associations of Antifungal Treatments With Prevention of Fungal Infection in Critically Ill Patients Without Neutropenia | Q40361579 | ||
| A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. | Q40833322 | ||
| Controlling a possible outbreak of Candida auris infection: lessons learnt from multiple interventions. | Q41931964 | ||
| Isolation of Candida auris from nine patients in Central America: Importance of accurate diagnosis and susceptibility testing | Q41994530 | ||
| Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories? | Q42326663 | ||
| Candida auris candidemia in Kuwait, 2014. | Q42787996 | ||
| Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features | Q43521723 | ||
| Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans | Q43552474 | ||
| In vitro and in vivo Evaluation of the Antifungal Activity of APX001A/APX001 Against Candida auris | Q47195606 | ||
| Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study | Q47583016 | ||
| Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen | Q48220845 | ||
| Development and Validation of a Real-Time PCR Assay for Rapid Detection of Candida auris from Surveillance Samples | Q49529517 | ||
| A Fatal Case of Candida auris and Candida tropicalis Candidemia in Neutropenic Patient | Q49566623 | ||
| In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model. | Q49598880 | ||
| Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. | Q49823075 | ||
| Persistent Candidemia Despite Appropriate Fungal Therapy: First Case of Candida auris from the United Arab Emirates | Q49923042 | ||
| Candida auris: a Review of the Literature. | Q49988058 | ||
| Surface disinfection challenges for Candida auris: an in-vitro study. | Q50083499 | ||
| A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. | Q50083987 | ||
| First report of sporadic cases of Candida auris in Colombia | Q50110515 | ||
| Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida auris | Q50145270 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| P304 | page(s) | 69 | |
| P577 | publication date | 2018-10-29 | |
| P1433 | published in | Journal of intensive care | Q27725973 |
| P1476 | title | Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris | |
| P478 | volume | 6 |
| Q92404341 | ABC Transporter Genes Show Upregulated Expression in Drug-Resistant Clinical Isolates of Candida auris: A Genome-Wide Characterization of ATP-Binding Cassette (ABC) Transporter Genes |
| Q89834562 | Antifungal Activity of an Original Amino-Isocyanonaphthalene (ICAN) Compound Family: Promising Broad Spectrum Antifungals |
| Q89510130 | Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? |
| Q91643627 | Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings |
| Q95642098 | Candida auris: From Multidrug Resistance to Pan-Resistant Strains |
| Q90737374 | Choosing the Right Antifungal Agent in ICU Patients |
| Q64064934 | Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan |
| Q92479570 | Development of Candida auris Short Tandem Repeat Typing and Its Application to a Global Collection of Isolates |
| Q91810281 | Evaluation of the Antifungal Activity of the Licania Rigida Leaf Ethanolic Extract against Biofilms Formed by Candida Sp. Isolates in Acrylic Resin Discs |
| Q90124888 | First Report of Candida auris Spondylodiscitis in Oman: A Rare Presentation |
| Q92128684 | Global warming "heating up" the ICU through Candida auris infections: the climate changes theory |
| Q64226654 | Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS |
| Q90146452 | Isolation of Candida auris from invasive and non-invasive samples of a patient suffering from vascular disease, Italy, July 2019 |
| Q98936603 | Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia |
| Q64359214 | New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility |
| Q94464436 | Nine Things Genomics Can Tell Us About Candida auris |
| Q98930173 | Origin of new emergent Coronavirus and Candida fungal diseases—Terrestrial or cosmic? |
| Q64287059 | Procalcitonin levels in candidemia versus bacteremia: a systematic review |
| Q91529794 | The Fungal Histone Acetyl Transferase Gcn5 Controls Virulence of the Human Pathogen Candida albicans through Multiple Pathways |
| Q64070550 | The global challenge of Candida auris in the intensive care unit |
Search more.